Intrinsiqq
Vera Therapeutics Inc. logo

Vera Therapeutics Inc. Insider Trading

VERA

Compare
Last 12 months

Insiders bought 250K and sold $8.44M on the open market.

83% of the selling was scheduled in advance under 10b5-1 plans.

Net open-market
−$8.19M
1 buy · 16 sales
Under a 10b5-1 plan
83%
of the value sold
Insiders who bought / sold
1 / 7
executives and directors
Last open-market buy
Dec 2025
Dec 11, 2025

Get an email when VERA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 1510b5-1 plan
    Marshall Fordyce
    President and CEO · sold 18,500 at $37.00
    685K
    7.3% of stake
  • Sep 210b5-1 plan
    Marshall Fordyce
    President and CEO · sold 18,500 at $35.12
    650K
    7.3% of stake
  • Jul 710b5-1 plan
    Marshall Fordyce
    President and CEO · sold 46,250 at avg $42.29
    $1.96M
    16% of stake
  • Jun 2310b5-1 plan
    Marshall Fordyce
    President and CEO · sold 18,500 at avg $37.93
    702K
    7.3% of stake
  • May 1210b5-1 plan
    Marshall Fordyce
    President and CEO · sold 18,500 at avg $36.74
    680K
    7.3% of stake
  • Apr 1410b5-1 plan
    Marshall Fordyce
    President and CEO · sold 22,951 at avg $44.05
    $1.01M
    4.8% of stake
  • Feb 23No plan
    Laurence Matthew Skelton
    Chief Commercial Officer · sold 1,582 at $41.98
    66K
    2.4% of stake
  • Feb 23No plan
    Robert Brenner
    Chief Medical Officer · sold 2,151 at $41.98
    90K
    4.1% of stake
  • Feb 23No plan
    Sean Grant
    Chief Financial Officer · sold 4,949 at $41.98
    208K
    4.0% of stake
  • Feb 23No plan
    Joseph R Young
    SVP, Finance, Chief Acct Offcr · sold 3,117 at $41.98
    131K
    4.6% of stake
  • Feb 23No plan
    Marshall Fordyce
    President and CEO · sold 16,925 at $41.98
    711K
    3.4% of stake
  • Feb 23No plan
    William D. Turner
    Chief Regulatory Officer · sold 2,187 at $41.98
    92K
    4.6% of stake
  • Feb 23No plan
    David Lee Johnson
    Chief Operating Officer · sold 2,579 at $41.98
    108K
    5.3% of stake
  • Dec 15, 202510b5-1 plan
    William D. Turner
    Chief Regulatory Officer · sold 10,000 at $50.08
    501K
    31% of stake
  • Dec 11, 2025
    Patrick G Enright
    Director · bought 5,882 at $42.50
    250K
    0.3% of stake
  • Dec 8, 202510b5-1 plan
    William D. Turner
    Chief Regulatory Officer · sold 10,000 at $45.31
    453K
    31% of stake
  • Dec 3, 202510b5-1 plan
    William D. Turner
    Chief Regulatory Officer · sold 10,000 at $40.00
    400K
    31% of stake
  • Nov 21, 2025No plan
    Jason S Carter
    Chief Legal Officer · sold 3,864 at $27.82
    107K
    7.3% of stake
  • Nov 11, 2025No plan
    Joseph R Young
    SVP, Finance, Chief Acct Offcr · sold 15,000 at $29.06
    436K
    21% of stake
  • Jun 23, 2025 – Jun 24, 2025
    Patrick G Enright
    Director · bought 250,000 at avg $21.11
    $5.28M
    7.5% of stake
  • Feb 21, 2025 – Feb 26, 202510b5-1 plan
    Marshall Fordyce
    President and CEO · sold 19,688 at avg $27.78
    547K
    4.4% of stake
  • Jan 8, 202510b5-1 plan
    Marshall Fordyce
    President and CEO · sold 17,500 at avg $41.74
    730K
    4.6% of stake
  • Dec 18, 202410b5-1 plan
    Marshall Fordyce
    President and CEO · sold 17,500 at avg $43.07
    754K
    4.6% of stake
  • Dec 11, 202410b5-1 plan
    Marshall Fordyce
    President and CEO · sold 17,500 at avg $46.94
    822K
    5.4% of stake
  • Nov 25, 202410b5-1 plan
    Marshall Fordyce
    President and CEO · sold 19,375 at avg $47.98
    930K
    5.9% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch VERA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with VERA

CompareIntrinsic value
IMNMImmunome Inc.
$15.68-5.60%10
SEPNSepterna, Inc.
$38.61-1.51%25
RANIRani Therapeutics Holdings Inc.
$0.51-12.03%10
AVIRAtea Pharmaceuticals Inc.
$3.96+0.76%40
IBOImpact Biomedical Inc.
$6.17+25.66%35
HROWHarrow Inc.
$30.41-5.35%15
SIGASiga Technologies Inc.
$2.40-9.43%24
XENEXenon Pharmaceuticals Inc.
$37.04-1.38%10

Held by ETFs

VERA is in 37 US ETFs. The largest of them, with VERA's weight in each:

Spot a number that looks wrong? Check it in VERA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing VERA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.